Insiders ORIC Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 27/06/2024 am IST			5-day change	1st Jan Change
6.63 ^USD	-1.63%		-7.66%	-27.93%

10/06	Transcript : ORIC Pharmaceuticals, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM
06/05	ORIC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Oric Pharmaceuticals Insider Sold Shares Worth $648,380, According to a Recent SEC Filing	09/03	MT
Oric Pharmaceuticals Insider Sold Shares Worth $489,346, According to a Recent SEC Filing	09/02	MT
Investor Caution Ahead of GDP Data, Jobless Claims Subdues Exchange-Traded Funds, Equity Futures Premarket	22/22/22	MT
Insider Buy: Oric Pharmaceuticals	16/22/16	MT
Insider Buy: Oric Pharmaceuticals	28/22/28	MT
ORIC Pharmaceuticals, Inc. Announces Directorate Changes	11/21/11	CI
Insider Sell: Oric Pharmaceuticals	15/21/15	MT
Insider Sell: Oric Pharmaceuticals	10/21/10	MT
ORIC Pharmaceuticals, Inc. Announces Board Changes	17/21/17	CI
ORIC Pharmaceuticals Appoints Lori Kunkel to Its Board of Directors	10/20/10	CI
ORIC Pharmaceuticals, Inc. Appoints Christian V. Kuhlen as General Counsel	02/20/02	CI
ORIC Pharmaceuticals Appoints Mardi C. Dier to Its Board of Directors	02/20/02	CI
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer	10/19/10	CI
ORIC Pharmaceuticals, Inc. Appoints Lori Friedman as Chief Scientific Officer	09/19/09	CI
ORIC Pharmaceuticals Names Edna Chow Maneval as Senior Vice President of Clinical Development	04/19/04	CI
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer	26/18/26	CI
ORIC Pharmaceuticals Appoints Pratik Multani as Chief Medical Officer	17/18/17	CI
ORIC Pharmaceuticals Announces Management Changes	07/18/07	CI
ORIC Pharmaceuticals, Inc. Announces Executive Changes	20/17/20	CI
ORIC Pharmaceuticals Announces Management Appointments	11/16/11	CI

No results for this search